Gary A Gwertzman, MD

Clinical Focus

• Endovenous Laser Treatment of Varicose Veins
• Vascular Surgery

• Endovenous Laser Treatment of Varicose Veins
• Vascular Surgery

Locations

3131 Kings Highway, Suite A-7, Brooklyn, NY, 11234

718-677-0109

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:5

Article:8

Selected Publications

• Managing central venous access during a health care crisis
• Enlargement of previously ligated popliteal aneurysm causing venous bypass graft occlusion
• Giant celiac artery aneurysm with associated visceral occlusive disease
• Carotid restenosis: Operative and endovascular management
• Patency and limb salvage for polytetrafluoroethylene bypasses with vein interposition cuffs
• Retinoblastoma protein: A molecular regulator of chronic venous insufficiency
• A strategy for increasing use of autogenous hemodialysis access procedures: Impact of preoperative noninvasive evaluation
• Laparoscopic Unroofing of Multiple Benign Liver Cysts with Intraperitoneal Drainage: A Case Report

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Gwertzman did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.